2016
DOI: 10.1016/j.jconrel.2016.06.027
|View full text |Cite
|
Sign up to set email alerts
|

Integrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living mice

Abstract: Lipid nanocarriers are considered as promising candidates for drug delivery and cancer targeting because of their low toxicity, biodegradability and capacity to encapsulate drugs and/or contrasting agents. However, their biomedical applications are currently limited because of a poor understanding of their integrity in vivo. To address this problem, we report on fluorescent nano-emulsion droplets of 100 nm size encapsulating lipophilic near-infrared cyanine 5.5 and 7.5 dyes with a help of bulky hydrophobic cou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
95
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1
1

Relationship

5
5

Authors

Journals

citations
Cited by 95 publications
(97 citation statements)
references
References 62 publications
2
95
0
Order By: Relevance
“…Using nanocarriers is a realistic solution for performing an efficient drug targeting, and thus an accumulation of the drug specifically on the desired location and not in the healthy tissues. Drug targeting is particularly crucial in antitumor therapies, taking benefit of the particular physico‐chemical and physiological properties of the tumor microenvironment for enhancing the nanocarrier accumulation . Associating the drug with a nanocarrier will, after in vivo administration, modify its biodistribution, pharmacokinetics, and elimination pathway in comparison with administrating the drug alone.…”
Section: Introductionmentioning
confidence: 99%
“…Using nanocarriers is a realistic solution for performing an efficient drug targeting, and thus an accumulation of the drug specifically on the desired location and not in the healthy tissues. Drug targeting is particularly crucial in antitumor therapies, taking benefit of the particular physico‐chemical and physiological properties of the tumor microenvironment for enhancing the nanocarrier accumulation . Associating the drug with a nanocarrier will, after in vivo administration, modify its biodistribution, pharmacokinetics, and elimination pathway in comparison with administrating the drug alone.…”
Section: Introductionmentioning
confidence: 99%
“…NIRF imaging is now widely accepted as one of the convenient methods to mimic the drug biodistribution in vivo. 48,49 NIRF imaging was applied to trace the biodistribution of LEs. As shown in Figure 8, most of the free DiR were distributed in the liver and spleen, while scarcely in the tumor at all time intervals.…”
Section: In Vivo Nirf Imagingmentioning
confidence: 99%
“…Upon nanoemulsion formation, the FRET pair was spontaneously incorporated into the oil core, triggering energy transfer due to the close proximity of the dye molecules. [14] As a result, the donor (DiO) peak’s intensity decreased while that of the FRET peak (DiO excited, DiI emission observed) increased (Figure 1b). The FRET/DiO intensity ratio is linearly related with the DiI/DiO concentration ratio (Figure 1c) and thus can be used as a measure of nanoemulsion formation progress.…”
mentioning
confidence: 98%